Guangzhou LBP Medicine Science & Technology Co Ltd Cash Flow Conversion Efficiency
Guangzhou LBP Medicine Science & Technology Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Guangzhou LBP Medicine Science & Technology Co Ltd (688393) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥29.17 Million ≈ $4.27 Million USD) by net assets (CN¥1.20 Billion ≈ $175.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Guangzhou LBP Medicine Science & Technology Co Ltd (2011–2024)
Cash flow conversion efficiency of Guangzhou LBP Medicine Science & Technology Co Ltd from 2011 to 2024. This chart illustrates how Guangzhou LBP Medicine Science & Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688393 stock price for real-time trading data and today's change.
Guangzhou LBP Medicine Science & Technology Co Ltd Cash Flow Conversion Ratio Explained
Guangzhou LBP Medicine Science & Technology Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Guangzhou LBP Medicine Science & Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangzhou LBP Medicine Science & Technology Co Ltd ranked by their cash flow conversion efficiency. Also see market cap of Guangzhou LBP Medicine Science & Technol for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Xingda International Holdings Limited
F:XDH
|
0.075x |
|
C&F Financial Corporation
NASDAQ:CFFI
|
0.008x |
|
Hyulim ROBOT Co.Ltd
KQ:090710
|
-0.070x |
|
Sino AG
XETRA:XTP
|
0.256x |
|
Inflection Point Acquisition Corp. VII
NASDAQ:IPXG
|
0.000x |
|
Nusantara Infrastructure Tbk
JK:META
|
0.015x |
|
Range Capital Acquisition Corp II Class A Ordinary Shares
NASDAQ:RNGT
|
0.000x |
|
Boryszew SA
WAR:BRS
|
0.012x |
Annual Cash Flow Conversion Efficiency for Guangzhou LBP Medicine Science & Technology Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Guangzhou LBP Medicine Science & Technology Co Ltd from 2011 to 2024. Review cash generation quality of Guangzhou LBP Medicine Science & Technol to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.23 Billion ≈ $180.24 Million |
CN¥3.54 Million ≈ $518.49K |
0.003x | -79.19% |
| 2023-12-31 | CN¥1.24 Billion ≈ $181.20 Million |
CN¥17.12 Million ≈ $2.51 Million |
0.014x | +73.94% |
| 2022-12-31 | CN¥1.22 Billion ≈ $178.87 Million |
CN¥9.72 Million ≈ $1.42 Million |
0.008x | -83.87% |
| 2021-12-31 | CN¥1.21 Billion ≈ $177.02 Million |
CN¥59.61 Million ≈ $8.72 Million |
0.049x | -37.07% |
| 2020-12-31 | CN¥1.17 Billion ≈ $170.85 Million |
CN¥91.43 Million ≈ $13.38 Million |
0.078x | -61.20% |
| 2019-12-31 | CN¥444.63 Million ≈ $65.06 Million |
CN¥89.74 Million ≈ $13.13 Million |
0.202x | +20.24% |
| 2018-12-31 | CN¥389.32 Million ≈ $56.97 Million |
CN¥65.35 Million ≈ $9.56 Million |
0.168x | -30.73% |
| 2017-12-31 | CN¥346.28 Million ≈ $50.67 Million |
CN¥83.92 Million ≈ $12.28 Million |
0.242x | +79.32% |
| 2016-12-31 | CN¥320.94 Million ≈ $46.96 Million |
CN¥43.37 Million ≈ $6.35 Million |
0.135x | +4270.59% |
| 2013-12-31 | CN¥215.00 Million ≈ $31.46 Million |
CN¥-696.70K ≈ $-101.95K |
-0.003x | -111.61% |
| 2012-12-31 | CN¥173.32 Million ≈ $25.36 Million |
CN¥4.84 Million ≈ $707.67K |
0.028x | +108.80% |
| 2011-12-31 | CN¥48.09 Million ≈ $7.04 Million |
CN¥-15.24 Million ≈ $-2.23 Million |
-0.317x | -- |
About Guangzhou LBP Medicine Science & Technology Co Ltd
Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China and internationally. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase… Read more